Titan Machinery Inc. (Nasdaq:TITN) announced today it will release
financial results for the third quarter ended October 31, 2014, on
Wednesday, December 10, 2014, followed by an investor conference call at
7:30 a.m. Central time (8:30 a.m. Eastern time).
Investors interested in participating in the live call can dial (888)
510-1785 from the U.S. International callers can dial (719) 325-2458.
Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical
company focused on the discovery, development and commercialization of
novel protein therapeutics for cancer and rare diseases, today announced
it will participate in several upcoming investor conferences.
The reported net asset values (NAVs) per share for Goldman Sachs MLP and
Energy Renaissance Fund (NYSE:GER) and Goldman Sachs MLP Income
Opportunities Fund (NYSE:GMZ) were incorrect on the dates below.
CAMBRIDGE, MA--(Marketwired - November 24, 2014) - Aastrom Biosciences, Inc. (NASDAQ: ASTM), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced the change of its corporate name to Vericel Corporation (NASDAQ: VCEL) ("Vericel"), effective immediately.
Halliburton Company (NYSE:HAL) today announced its Board of Directors
has appointed Executive Vice President and Chief Financial Officer Mark
McCollum to the new role of Executive Vice President and Chief
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.